An ophthalmology research team at the University of Wisconsin-Madison took part in a nationwide clinical trial comparing treatments for a form of diabetic eye disease.
Europe Approves Western World’s First Stem-Cell Therapy for Rare Eye Condition
Europe has approved the Western world’s first medicine containing stem cells to treat a rare condition caused by burns to the eye, marking a milestone in the use of the technology. International Approvals
Ophthalmic community mourns loss of Richard P. Kratz
Richard P. Kratz, MD, an early proponent of phacoemulsification and IOL implantation and a former student of Sir Harold Ridley, died recently. He was 95.Kratz, whose mother was a physician, was born in Los Angeles in 1920 and displayed an interest in science and medicine at a young age. He earned his bachelor’s degree from Occidental College in 1942 and obtained his medical degree from the University of Southern California in 1946.
Tecnis Symfony IOL achieves good vision at all distances
ISTANBUL — First results of the Tecnis Symfony extended range of vision IOL from Abbott Medical Optics show a high degree of spectacle independence with good vision at all distances and excellent visual quality, according to one speaker.“This lens looks like a multifocal, but it is not. The unique proprietary echelette design creates only one elongated focus,” Ante Barišić, MD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.
Novel ocular biometer enhances precision of IOL power calculation
ISTANBUL — A novel ocular biometer that combines a Purkinje imaging method and an OCT device has the potential to produce highly accurate and reproducible measurements for IOL power calculation, according to one speaker.“It might be a promising solution for both normal and challenging cases, such as post-LASIK eyes or implantation of toric IOLs,” Michael Mrochen, PhD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.
IRIDEX to unveil Cyclo G6 laser system for treatment of glaucoma at AGS annual congress
IRIDEX Corporation today announced that it will debut Cyclo G6, the Company’s first laser platform dedicated to the treatment of glaucoma, at this year’s annual congress of the American Glaucoma Society.